Moreover, we prioritized drug-targets such as melatonin, resveratrol, eugenol, lapatinib, geldanamycin and azathioprine which interacted with ESR1, ERBB2, HSP90AB1 and RAC1, respectively and shown associations in diabetes treatment in experimental models of T1D. This evidence concerns the gene HSP90AB1 and diabetes mellitus.